HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ronnie Aronson Selected Research

lixisenatide

7/2022Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial.
1/2017Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.
11/2016Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial.
8/2016Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.
9/2014Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.
8/2014Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials.
6/2014Efficacy and safety of the glucagon-like peptide-1 receptor agonist lixisenatide versus the dipeptidyl peptidase-4 inhibitor sitagliptin in young (<50 years) obese patients with type 2 diabetes mellitus.
11/2013Optimizing glycemic control: lixisenatide and basal insulin in combination therapy for the treatment of Type 2 diabetes mellitus.
9/2013Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).
9/2013Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ronnie Aronson Research Topics

Disease

38Type 2 Diabetes Mellitus (MODY)
09/2023 - 06/2010
18Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2023 - 10/2014
17Hypoglycemia (Reactive Hypoglycemia)
01/2023 - 06/2010
7Body Weight (Weight, Body)
11/2020 - 09/2013
6Weight Gain
08/2016 - 06/2010
4Vomiting
01/2021 - 09/2013
4Nausea
01/2021 - 09/2013
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 03/2014
4Hyperglycemia
01/2019 - 09/2013
2Infections
10/2021 - 01/2018
2Weight Loss (Weight Reduction)
10/2019 - 06/2014
1Hepatitis B
10/2021
1Celiac Disease (Celiac Sprue)
01/2020
1Albuminuria
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2018
1Body Weight Changes
08/2016
1Overweight
08/2016
1Obesity
06/2014
1Kidney Diseases (Kidney Disease)
03/2014
1Hypertension (High Blood Pressure)
03/2014
1Diabetes Mellitus
03/2014
1Diabetes Complications
08/2012

Drug/Important Bio-Agent (IBA)

25Insulin (Novolin)FDA Link
09/2023 - 06/2010
20Glucose (Dextrose)FDA LinkGeneric
01/2023 - 06/2010
11lixisenatideIBA
07/2022 - 09/2013
8Insulin Glargine (Lantus)FDA Link
07/2022 - 06/2010
6Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2022 - 07/2012
6Metformin (Glucophage)FDA LinkGeneric
01/2020 - 07/2012
4Glucagon (Glukagon)FDA Link
01/2023 - 01/2021
4Hypoglycemic Agents (Hypoglycemics)IBA
07/2022 - 08/2014
4Glucagon-Like Peptide-1 ReceptorIBA
02/2017 - 09/2013
3Blood Glucose (Blood Sugar)IBA
10/2019 - 08/2017
2dasiglucagonIBA
01/2023 - 01/2021
2LDL CholesterolIBA
10/2020 - 03/2014
2dapagliflozinIBA
01/2020 - 11/2017
2Uric Acid (Urate)IBA
01/2020 - 01/2019
2Allopurinol (Remid)FDA LinkGeneric
01/2020 - 01/2019
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
10/2019 - 08/2016
2LinagliptinIBA
05/2015 - 07/2012
1Insulin Lispro (Humalog)FDA Link
01/2023
1Biosimilar PharmaceuticalsIBA
07/2022
1Gliclazide (Diamicron)IBA
07/2022
1Anti-Idiotypic AntibodiesIBA
10/2021
1VaccinesIBA
10/2021
1semaglutideIBA
11/2020
1Ezetimibe (Zetia)FDA Link
10/2020
1oxidized low density lipoproteinIBA
10/2020
1Colesevelam Hydrochloride (Welchol)FDA Link
10/2020
1insulin degludecIBA
01/2020
1SuspensionsIBA
01/2020
1SodiumIBA
11/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
11/2019
1CanagliflozinIBA
11/2019
1TabletsIBA
10/2019
1LiraglutideFDA Link
10/2019
1dulaglutideIBA
10/2019
1ertugliflozinIBA
01/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
02/2017
1insulin glulisineFDA Link
08/2016
1empagliflozinIBA
05/2015
1C-PeptideIBA
10/2014
1Monoclonal AntibodiesIBA
10/2014
1otelixizumabIBA
10/2014
1Sitagliptin Phosphate (Januvia)FDA Link
06/2014
1Hemoglobins (Hemoglobin)IBA
03/2014
1Triglycerides (Triacylglycerol)IBA
03/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2014
1HDL CholesterolIBA
03/2014
1Complement System Proteins (Complement)IBA
11/2013
1Short-Acting InsulinIBA
09/2013
1Insulin Detemir (Levemir)FDA Link
06/2010

Therapy/Procedure

17Therapeutics
01/2023 - 07/2012
13Glycemic Control
11/2017 - 07/2012
7Injections
01/2020 - 09/2013
1Gluten-Free Diet
01/2020